Monday, October 15, 2018 — The Organization of Eastern Caribbean States/Pharmaceutical Procurement Service (OECS/PPS) is announcing a new partnership with the Caribbean Public Health Agency/ Caribbean Regulatory System (CARPHA/CRS) that will require all anti-retroviral (ARVs) medicines to receive approval by the CRS in order to participate in the upcoming OECS/PPS ARV tender in June of 2019.
The CRS is a regional regulatory mechanism, endorsed by Ministers of Health from CARICOM states, that is implemented in technical collaboration with the Pan American Health Organization/World Health Organization (PAHO/WHO). The CRS seeks to increase the number of quality products on the CARICOM market through reliance on a select group of reference authorities for medicines approvals, including the US Food and Drug Administration and WHO Prequalification Program.
The OECS/PPS partnership with CRS will ensure that regulatory assurance can be provided to these vital and essential medicines, and that it can be done in a sustainable way that leverages the knowledge and expertise of local institutions. Suppliers will be invited to submit applications for ARVs on the OECS/PPS formulary HERE, and in accordance with CRS requirements, which can be found HERE.
For more information, please contact the OECS/PPS at: pps@oecs.int or CRS at: CRSregistration@CARPHA.org
Disclaimer
This article was posted in its entirety as received by SKNVibes.com. This media house does not correct any spelling or grammatical error within press releases and commentaries. The views expressed therein are not necessarily those of SKNVibes.com, its sponsors or advertisers